Skip to main content

FDA recall, , Moderate risk

Genius Review Station Display (Barco Monitor)

The Genius Review Station Display can be operated outside its validated configuration due to user modifications.

What happened

Hologic, Inc., of Marlborough, Massachusetts, began a recall on March 23, 2026, of the Genius" Review Station Display (Barco Monitor), model CMP-01669, a component of the Genius" Digital Diagnostics System with the Genius" Cervical AI Algorithm. The recall was added to the FDA's Enforcement Report and classified on April 24, 2026, and appeared in the FDA's weekly enforcement report on May 6, 2026.

The recall was initiated because certain devices were operated outside the validated and FDA-cleared display configuration due to user modification of manufacturer-installed settings, including disabling Barco Application Appearance Manager, altering calibration and compliance parameters, and adjusting additional display-related settings.

The affected devices were distributed worldwide, including US Nationwide and countries in Asia Pacific, Europe, and the Middle East.

What to do

If a code on your device is listed below:

  1. This field correction is being conducted to restore affected system to the validated configuration and reinforce proper use in accordance with the Operator's Manual.

Is yours affected?

Affected if its model number matches.

  1. Genius Review Station Display (Barco Monitor)

    Model number
    • CMP-01669

Recall details

Company began the recall
Sold in

Worldwide distribution - US Nationwide and the countries of Asia Pacific, Europe, and the Middle East.

Company
Hologic, IncMarlborough, Massachusetts
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98487
Recall number
Z-1949-2026
Quantity recalled
1200 units
Recall type
Voluntary: Firm initiated
How the company first told customers
Letter

All recalls from Hologic, Inc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)